SAB BIOTHERAPEUTICS INC (SABS) Stock Price, Quote, News and Overview

What is the stock price of SAB BIOTHERAPEUTICS INC today?

The current stock price of SABS is 1.82 USD. The price decreased by -6.67% in the last trading session.

What is the ticker symbol for SAB BIOTHERAPEUTICS INC stock?

The exchange symbol of SAB BIOTHERAPEUTICS INC is SABS and it is listed on the Nasdaq exchange.

On which exchange is SABS stock listed?

SABS stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for SAB BIOTHERAPEUTICS INC stock?

10 analysts have analysed SABS and the average price target is 12.65 USD. This implies a price increase of 594.95% is expected in the next year compared to the current price of 1.82. Check the SAB BIOTHERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is SAB BIOTHERAPEUTICS INC worth?

SAB BIOTHERAPEUTICS INC (SABS) has a market capitalization of 16.80M USD. This makes SABS a Nano Cap stock.

How many employees does SAB BIOTHERAPEUTICS INC have?

SAB BIOTHERAPEUTICS INC (SABS) currently has 57 employees.

What are the support and resistance levels for SAB BIOTHERAPEUTICS INC (SABS) stock?

SAB BIOTHERAPEUTICS INC (SABS) has a resistance level at 2.07. Check the full technical report for a detailed analysis of SABS support and resistance levels.

Is SAB BIOTHERAPEUTICS INC (SABS) expected to grow?

The Revenue of SAB BIOTHERAPEUTICS INC (SABS) is expected to grow by 0.6% in the next year. Check the estimates tab for more information on the SABS EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy SAB BIOTHERAPEUTICS INC (SABS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of SABS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of SABS, evaluating the profitability, health, valuation and growth aspects
• SAB BIOTHERAPEUTICS INC (SABS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• SAB BIOTHERAPEUTICS INC (SABS) Sales and EPS estimates to see what analysts future expectations are.
• SAB BIOTHERAPEUTICS INC (SABS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• SAB BIOTHERAPEUTICS INC (SABS) Insider and Institutional Ownership to learn about the owners and their transactions.
• SAB BIOTHERAPEUTICS INC (SABS) Stock Chart to make your own analysis
• SAB BIOTHERAPEUTICS INC (SABS) Latest news and press-releases to stay up to date.

Does SAB BIOTHERAPEUTICS INC (SABS) stock pay dividends?

SABS does not pay a dividend.

When does SAB BIOTHERAPEUTICS INC (SABS) report earnings?

SAB BIOTHERAPEUTICS INC (SABS) will report earnings on 2025-03-26, after the market close.

What is the Price/Earnings (PE) ratio of SAB BIOTHERAPEUTICS INC (SABS)?

SAB BIOTHERAPEUTICS INC (SABS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.89).

What is the Short Interest ratio of SAB BIOTHERAPEUTICS INC (SABS) stock?

The outstanding short interest for SAB BIOTHERAPEUTICS INC (SABS) is 1.59% of its float. Check the ownership tab for more information on the SABS short interest.

ChartMill assigns a fundamental rating of 1 / 10 to SABS. SABS may be in some trouble as it scores bad on both profitability and health.

Over the last trailing twelve months SABS reported a non-GAAP Earnings per Share(EPS) of -5.89. The EPS decreased by -43.66% compared to the year before.

ChartMill assigns a Buy % Consensus number of 84% to SABS. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of 48.44% and a revenue growth 0.6% for SABS